Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction Cancer.
Soto M, Filbert EL, Yang H, Starzinski S, Starzinski A, Gin M, Chen B, Le P, Li T, Bol B, Cheung A, Zhang L, Hsu FJ, Ko A, Fong L, Keenan BP.
Soto M, et al. Among authors: bol b.
Cancer Res Commun. 2024 Jan 25;4(1):200-212. doi: 10.1158/2767-9764.CRC-23-0550.
Cancer Res Commun. 2024.
PMID: 38181044
Free PMC article.